SHL TELEMEDICINE LTD-ADR (SHLT) Stock Fundamental Analysis

NASDAQ:SHLT • US78423T2006

2.05 USD
-0.03 (-1.44%)
Last: Apr 2, 2025, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SHLT. SHLT was compared to 101 industry peers in the Health Care Providers & Services industry. While SHLT seems to be doing ok healthwise, there are quite some concerns on its profitability. SHLT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SHLT has reported negative net income.
  • SHLT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SHLT reported negative net income in multiple years.
  • In multiple years SHLT reported negative operating cash flow during the last 5 years.
SHLT Yearly Net Income VS EBIT VS OCF VS FCFSHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

  • With a Return On Assets value of -8.60%, SHLT is not doing good in the industry: 71.96% of the companies in the same industry are doing better.
  • With a Return On Equity value of -13.13%, SHLT is not doing good in the industry: 62.62% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROIC N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
SHLT Yearly ROA, ROE, ROICSHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

  • SHLT has a Gross Margin of 45.73%. This is in the better half of the industry: SHLT outperforms 73.83% of its industry peers.
  • SHLT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SHLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
SHLT Yearly Profit, Operating, Gross MarginsSHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SHLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SHLT has more shares outstanding than it did 1 year ago.
  • SHLT has a better debt/assets ratio than last year.
SHLT Yearly Shares OutstandingSHLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
SHLT Yearly Total Debt VS Total AssetsSHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -0.08, we must say that SHLT is in the distress zone and has some risk of bankruptcy.
  • SHLT has a worse Altman-Z score (-0.08) than 76.64% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that SHLT is not too dependend on debt financing.
  • The Debt to Equity ratio of SHLT (0.20) is better than 69.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC7.08%
SHLT Yearly LT Debt VS Equity VS FCFSHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

  • SHLT has a Current Ratio of 2.17. This indicates that SHLT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.17, SHLT is doing good in the industry, outperforming 76.64% of the companies in the same industry.
  • A Quick Ratio of 1.98 indicates that SHLT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.98, SHLT is in the better half of the industry, outperforming 74.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.98
SHLT Yearly Current Assets VS Current LiabilitesSHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for SHLT have decreased strongly by -282.35% in the last year.
  • Looking at the last year, SHLT shows a decrease in Revenue. The Revenue has decreased by -2.04% in the last year.
  • SHLT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.16% yearly.
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHLT Yearly Revenue VS EstimatesSHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
SHLT Yearly EPS VS EstimatesSHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • SHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHLT Price Earnings VS Forward Price EarningsSHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SHLT Per share dataSHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for SHLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SHL TELEMEDICINE LTD-ADR

NASDAQ:SHLT (4/2/2025, 8:00:02 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)04-24
Inst Owners27.15%
Inst Owner Change0%
Ins Owners5.8%
Ins Owner ChangeN/A
Market Cap33.60M
Revenue(TTM)55.94M
Net Income(TTM)-8.84M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF 23.16
P/B 0.5
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.09
OCFY4.32%
SpS3.41
BVpS4.11
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -13.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.73%
FCFM N/A
ROA(3y)-5.73%
ROA(5y)-1.45%
ROE(3y)-11.52%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-6.47%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.04%
Cap/Sales 9.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.98
Altman-Z -0.08
F-Score5
WACC7.08%
ROIC/WACCN/A
Cap/Depr(3y)76.24%
Cap/Depr(5y)63.01%
Cap/Sales(3y)9.3%
Cap/Sales(5y)7.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-282.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.04%
Revenue growth 3Y12.43%
Revenue growth 5Y3.16%
Sales Q2Q%-3.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.12%
OCF growth 3YN/A
OCF growth 5YN/A

SHL TELEMEDICINE LTD-ADR / SHLT FAQ

Can you provide the ChartMill fundamental rating for SHL TELEMEDICINE LTD-ADR?

ChartMill assigns a fundamental rating of 2 / 10 to SHLT.


What is the valuation status of SHL TELEMEDICINE LTD-ADR (SHLT) stock?

ChartMill assigns a valuation rating of 0 / 10 to SHL TELEMEDICINE LTD-ADR (SHLT). This can be considered as Overvalued.


What is the profitability of SHLT stock?

SHL TELEMEDICINE LTD-ADR (SHLT) has a profitability rating of 1 / 10.


Can you provide the financial health for SHLT stock?

The financial health rating of SHL TELEMEDICINE LTD-ADR (SHLT) is 4 / 10.